secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2022-05-10T23:59:59+00:00
Accession:  0001171843-22-003516
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics Q1 revenue up 14% to $6.5M; declares increased dividend of $0.07/share
--------------------------------------------------------------------------------

- Revenue $6.5M vs $5.7M (+14% YoY); domestic revenue up 17%, international down 42%.
- Net income $39k ($0.01 diluted EPS) vs $83k; prior year included $800k ERC benefit.
- Declares cash dividend of $0.07/share, payable June 24, 2022, to holders of record May 27, 2022.
- Cash $2.1M, working capital $5.2M; equipment financing $1.1M, repaid $11.1M since May 2014.
- Strategic alternatives review ongoing; CEO cites momentum in oil/gas, transport, and manufacturing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184322003516/0001171843-22-003516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184322003516/f8k_051022.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-003516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer